Global Biosimilars & Follow-on-Biologics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Biosimilars & Follow-on-Biologics market size was valued at USD 23140 million in 2023 and is forecast to a readjusted size of USD 59180 million by 2030 with a CAGR of 14.4% during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Biosimilars & Follow-on-Biologics industry chain, the market status of Blood Disorders (Human Growth Hormone, Erythropoietin), Oncology Diseases (Human Growth Hormone, Erythropoietin), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Biosimilars & Follow-on-Biologics.
Regionally, the report analyzes the Biosimilars & Follow-on-Biologics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Biosimilars & Follow-on-Biologics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Biosimilars & Follow-on-Biologics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Biosimilars & Follow-on-Biologics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Human Growth Hormone, Erythropoietin).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Biosimilars & Follow-on-Biologics market.
Regional Analysis: The report involves examining the Biosimilars & Follow-on-Biologics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Biosimilars & Follow-on-Biologics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Biosimilars & Follow-on-Biologics:
Company Analysis: Report covers individual Biosimilars & Follow-on-Biologics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Biosimilars & Follow-on-Biologics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Blood Disorders, Oncology Diseases).
Technology Analysis: Report covers specific technologies relevant to Biosimilars & Follow-on-Biologics. It assesses the current state, advancements, and potential future developments in Biosimilars & Follow-on-Biologics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Biosimilars & Follow-on-Biologics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Biosimilars & Follow-on-Biologics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Biosimilars & Follow-on-Biologics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biosimilars & Follow-on-Biologics, with revenue, gross margin and global market share of Biosimilars & Follow-on-Biologics from 2019 to 2024.
Chapter 3, the Biosimilars & Follow-on-Biologics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Biosimilars & Follow-on-Biologics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biosimilars & Follow-on-Biologics.
Chapter 13, to describe Biosimilars & Follow-on-Biologics research findings and conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Biosimilars & Follow-on-Biologics industry chain, the market status of Blood Disorders (Human Growth Hormone, Erythropoietin), Oncology Diseases (Human Growth Hormone, Erythropoietin), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Biosimilars & Follow-on-Biologics.
Regionally, the report analyzes the Biosimilars & Follow-on-Biologics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Biosimilars & Follow-on-Biologics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Biosimilars & Follow-on-Biologics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Biosimilars & Follow-on-Biologics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Human Growth Hormone, Erythropoietin).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Biosimilars & Follow-on-Biologics market.
Regional Analysis: The report involves examining the Biosimilars & Follow-on-Biologics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Biosimilars & Follow-on-Biologics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Biosimilars & Follow-on-Biologics:
Company Analysis: Report covers individual Biosimilars & Follow-on-Biologics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Biosimilars & Follow-on-Biologics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Blood Disorders, Oncology Diseases).
Technology Analysis: Report covers specific technologies relevant to Biosimilars & Follow-on-Biologics. It assesses the current state, advancements, and potential future developments in Biosimilars & Follow-on-Biologics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Biosimilars & Follow-on-Biologics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Biosimilars & Follow-on-Biologics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Human Growth Hormone
- Erythropoietin
- Monoclonal Antibodies
- Insulin
- Interferon
- Granulocyte-Colony Stimulating Factor
- Peptide
- Others
- Blood Disorders
- Oncology Diseases
- Chronic and Autoimmune Diseases
- Growth Hormone Deficiencies
- Others
- Novartis
- Synthon Pharmaceuticals
- Teva Pharmaceutical Industries
- LG Life Sciences
- Celltrion
- Biocon
- Hospira
- Merck Group
- Biogen idec, Inc.
- Genentech (Roche Group)
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Biosimilars & Follow-on-Biologics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biosimilars & Follow-on-Biologics, with revenue, gross margin and global market share of Biosimilars & Follow-on-Biologics from 2019 to 2024.
Chapter 3, the Biosimilars & Follow-on-Biologics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Biosimilars & Follow-on-Biologics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biosimilars & Follow-on-Biologics.
Chapter 13, to describe Biosimilars & Follow-on-Biologics research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Biosimilars & Follow-on-Biologics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Biosimilars & Follow-on-Biologics by Type
1.3.1 Overview: Global Biosimilars & Follow-on-Biologics Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Biosimilars & Follow-on-Biologics Consumption Value Market Share by Type in 2023
1.3.3 Human Growth Hormone
1.3.4 Erythropoietin
1.3.5 Monoclonal Antibodies
1.3.6 Insulin
1.3.7 Interferon
1.3.8 Granulocyte-Colony Stimulating Factor
1.3.9 Peptide
1.3.10 Others
1.4 Global Biosimilars & Follow-on-Biologics Market by Application
1.4.1 Overview: Global Biosimilars & Follow-on-Biologics Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Blood Disorders
1.4.3 Oncology Diseases
1.4.4 Chronic and Autoimmune Diseases
1.4.5 Growth Hormone Deficiencies
1.4.6 Others
1.5 Global Biosimilars & Follow-on-Biologics Market Size & Forecast
1.6 Global Biosimilars & Follow-on-Biologics Market Size and Forecast by Region
1.6.1 Global Biosimilars & Follow-on-Biologics Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Biosimilars & Follow-on-Biologics Market Size by Region, (2019-2030)
1.6.3 North America Biosimilars & Follow-on-Biologics Market Size and Prospect (2019-2030)
1.6.4 Europe Biosimilars & Follow-on-Biologics Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Biosimilars & Follow-on-Biologics Market Size and Prospect (2019-2030)
1.6.6 South America Biosimilars & Follow-on-Biologics Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Biosimilars & Follow-on-Biologics Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Biosimilars & Follow-on-Biologics Product and Solutions
2.1.4 Novartis Biosimilars & Follow-on-Biologics Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Novartis Recent Developments and Future Plans
2.2 Synthon Pharmaceuticals
2.2.1 Synthon Pharmaceuticals Details
2.2.2 Synthon Pharmaceuticals Major Business
2.2.3 Synthon Pharmaceuticals Biosimilars & Follow-on-Biologics Product and Solutions
2.2.4 Synthon Pharmaceuticals Biosimilars & Follow-on-Biologics Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Synthon Pharmaceuticals Recent Developments and Future Plans
2.3 Teva Pharmaceutical Industries
2.3.1 Teva Pharmaceutical Industries Details
2.3.2 Teva Pharmaceutical Industries Major Business
2.3.3 Teva Pharmaceutical Industries Biosimilars & Follow-on-Biologics Product and Solutions
2.3.4 Teva Pharmaceutical Industries Biosimilars & Follow-on-Biologics Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Teva Pharmaceutical Industries Recent Developments and Future Plans
2.4 LG Life Sciences
2.4.1 LG Life Sciences Details
2.4.2 LG Life Sciences Major Business
2.4.3 LG Life Sciences Biosimilars & Follow-on-Biologics Product and Solutions
2.4.4 LG Life Sciences Biosimilars & Follow-on-Biologics Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 LG Life Sciences Recent Developments and Future Plans
2.5 Celltrion
2.5.1 Celltrion Details
2.5.2 Celltrion Major Business
2.5.3 Celltrion Biosimilars & Follow-on-Biologics Product and Solutions
2.5.4 Celltrion Biosimilars & Follow-on-Biologics Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Celltrion Recent Developments and Future Plans
2.6 Biocon
2.6.1 Biocon Details
2.6.2 Biocon Major Business
2.6.3 Biocon Biosimilars & Follow-on-Biologics Product and Solutions
2.6.4 Biocon Biosimilars & Follow-on-Biologics Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Biocon Recent Developments and Future Plans
2.7 Hospira
2.7.1 Hospira Details
2.7.2 Hospira Major Business
2.7.3 Hospira Biosimilars & Follow-on-Biologics Product and Solutions
2.7.4 Hospira Biosimilars & Follow-on-Biologics Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Hospira Recent Developments and Future Plans
2.8 Merck Group
2.8.1 Merck Group Details
2.8.2 Merck Group Major Business
2.8.3 Merck Group Biosimilars & Follow-on-Biologics Product and Solutions
2.8.4 Merck Group Biosimilars & Follow-on-Biologics Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Merck Group Recent Developments and Future Plans
2.9 Biogen idec, Inc.
2.9.1 Biogen idec, Inc. Details
2.9.2 Biogen idec, Inc. Major Business
2.9.3 Biogen idec, Inc. Biosimilars & Follow-on-Biologics Product and Solutions
2.9.4 Biogen idec, Inc. Biosimilars & Follow-on-Biologics Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Biogen idec, Inc. Recent Developments and Future Plans
2.10 Genentech (Roche Group)
2.10.1 Genentech (Roche Group) Details
2.10.2 Genentech (Roche Group) Major Business
2.10.3 Genentech (Roche Group) Biosimilars & Follow-on-Biologics Product and Solutions
2.10.4 Genentech (Roche Group) Biosimilars & Follow-on-Biologics Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Genentech (Roche Group) Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Biosimilars & Follow-on-Biologics Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Biosimilars & Follow-on-Biologics by Company Revenue
3.2.2 Top 3 Biosimilars & Follow-on-Biologics Players Market Share in 2023
3.2.3 Top 6 Biosimilars & Follow-on-Biologics Players Market Share in 2023
3.3 Biosimilars & Follow-on-Biologics Market: Overall Company Footprint Analysis
3.3.1 Biosimilars & Follow-on-Biologics Market: Region Footprint
3.3.2 Biosimilars & Follow-on-Biologics Market: Company Product Type Footprint
3.3.3 Biosimilars & Follow-on-Biologics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Biosimilars & Follow-on-Biologics Consumption Value and Market Share by Type (2019-2024)
4.2 Global Biosimilars & Follow-on-Biologics Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Biosimilars & Follow-on-Biologics Consumption Value Market Share by Application (2019-2024)
5.2 Global Biosimilars & Follow-on-Biologics Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Biosimilars & Follow-on-Biologics Consumption Value by Type (2019-2030)
6.2 North America Biosimilars & Follow-on-Biologics Consumption Value by Application (2019-2030)
6.3 North America Biosimilars & Follow-on-Biologics Market Size by Country
6.3.1 North America Biosimilars & Follow-on-Biologics Consumption Value by Country (2019-2030)
6.3.2 United States Biosimilars & Follow-on-Biologics Market Size and Forecast (2019-2030)
6.3.3 Canada Biosimilars & Follow-on-Biologics Market Size and Forecast (2019-2030)
6.3.4 Mexico Biosimilars & Follow-on-Biologics Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Biosimilars & Follow-on-Biologics Consumption Value by Type (2019-2030)
7.2 Europe Biosimilars & Follow-on-Biologics Consumption Value by Application (2019-2030)
7.3 Europe Biosimilars & Follow-on-Biologics Market Size by Country
7.3.1 Europe Biosimilars & Follow-on-Biologics Consumption Value by Country (2019-2030)
7.3.2 Germany Biosimilars & Follow-on-Biologics Market Size and Forecast (2019-2030)
7.3.3 France Biosimilars & Follow-on-Biologics Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Biosimilars & Follow-on-Biologics Market Size and Forecast (2019-2030)
7.3.5 Russia Biosimilars & Follow-on-Biologics Market Size and Forecast (2019-2030)
7.3.6 Italy Biosimilars & Follow-on-Biologics Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Biosimilars & Follow-on-Biologics Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Biosimilars & Follow-on-Biologics Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Biosimilars & Follow-on-Biologics Market Size by Region
8.3.1 Asia-Pacific Biosimilars & Follow-on-Biologics Consumption Value by Region (2019-2030)
8.3.2 China Biosimilars & Follow-on-Biologics Market Size and Forecast (2019-2030)
8.3.3 Japan Biosimilars & Follow-on-Biologics Market Size and Forecast (2019-2030)
8.3.4 South Korea Biosimilars & Follow-on-Biologics Market Size and Forecast (2019-2030)
8.3.5 India Biosimilars & Follow-on-Biologics Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Biosimilars & Follow-on-Biologics Market Size and Forecast (2019-2030)
8.3.7 Australia Biosimilars & Follow-on-Biologics Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Biosimilars & Follow-on-Biologics Consumption Value by Type (2019-2030)
9.2 South America Biosimilars & Follow-on-Biologics Consumption Value by Application (2019-2030)
9.3 South America Biosimilars & Follow-on-Biologics Market Size by Country
9.3.1 South America Biosimilars & Follow-on-Biologics Consumption Value by Country (2019-2030)
9.3.2 Brazil Biosimilars & Follow-on-Biologics Market Size and Forecast (2019-2030)
9.3.3 Argentina Biosimilars & Follow-on-Biologics Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Biosimilars & Follow-on-Biologics Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Biosimilars & Follow-on-Biologics Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Biosimilars & Follow-on-Biologics Market Size by Country
10.3.1 Middle East & Africa Biosimilars & Follow-on-Biologics Consumption Value by Country (2019-2030)
10.3.2 Turkey Biosimilars & Follow-on-Biologics Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Biosimilars & Follow-on-Biologics Market Size and Forecast (2019-2030)
10.3.4 UAE Biosimilars & Follow-on-Biologics Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Biosimilars & Follow-on-Biologics Market Drivers
11.2 Biosimilars & Follow-on-Biologics Market Restraints
11.3 Biosimilars & Follow-on-Biologics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Biosimilars & Follow-on-Biologics Industry Chain
12.2 Biosimilars & Follow-on-Biologics Upstream Analysis
12.3 Biosimilars & Follow-on-Biologics Midstream Analysis
12.4 Biosimilars & Follow-on-Biologics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Biosimilars & Follow-on-Biologics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Biosimilars & Follow-on-Biologics by Type
1.3.1 Overview: Global Biosimilars & Follow-on-Biologics Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Biosimilars & Follow-on-Biologics Consumption Value Market Share by Type in 2023
1.3.3 Human Growth Hormone
1.3.4 Erythropoietin
1.3.5 Monoclonal Antibodies
1.3.6 Insulin
1.3.7 Interferon
1.3.8 Granulocyte-Colony Stimulating Factor
1.3.9 Peptide
1.3.10 Others
1.4 Global Biosimilars & Follow-on-Biologics Market by Application
1.4.1 Overview: Global Biosimilars & Follow-on-Biologics Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Blood Disorders
1.4.3 Oncology Diseases
1.4.4 Chronic and Autoimmune Diseases
1.4.5 Growth Hormone Deficiencies
1.4.6 Others
1.5 Global Biosimilars & Follow-on-Biologics Market Size & Forecast
1.6 Global Biosimilars & Follow-on-Biologics Market Size and Forecast by Region
1.6.1 Global Biosimilars & Follow-on-Biologics Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Biosimilars & Follow-on-Biologics Market Size by Region, (2019-2030)
1.6.3 North America Biosimilars & Follow-on-Biologics Market Size and Prospect (2019-2030)
1.6.4 Europe Biosimilars & Follow-on-Biologics Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Biosimilars & Follow-on-Biologics Market Size and Prospect (2019-2030)
1.6.6 South America Biosimilars & Follow-on-Biologics Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Biosimilars & Follow-on-Biologics Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Biosimilars & Follow-on-Biologics Product and Solutions
2.1.4 Novartis Biosimilars & Follow-on-Biologics Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Novartis Recent Developments and Future Plans
2.2 Synthon Pharmaceuticals
2.2.1 Synthon Pharmaceuticals Details
2.2.2 Synthon Pharmaceuticals Major Business
2.2.3 Synthon Pharmaceuticals Biosimilars & Follow-on-Biologics Product and Solutions
2.2.4 Synthon Pharmaceuticals Biosimilars & Follow-on-Biologics Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Synthon Pharmaceuticals Recent Developments and Future Plans
2.3 Teva Pharmaceutical Industries
2.3.1 Teva Pharmaceutical Industries Details
2.3.2 Teva Pharmaceutical Industries Major Business
2.3.3 Teva Pharmaceutical Industries Biosimilars & Follow-on-Biologics Product and Solutions
2.3.4 Teva Pharmaceutical Industries Biosimilars & Follow-on-Biologics Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Teva Pharmaceutical Industries Recent Developments and Future Plans
2.4 LG Life Sciences
2.4.1 LG Life Sciences Details
2.4.2 LG Life Sciences Major Business
2.4.3 LG Life Sciences Biosimilars & Follow-on-Biologics Product and Solutions
2.4.4 LG Life Sciences Biosimilars & Follow-on-Biologics Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 LG Life Sciences Recent Developments and Future Plans
2.5 Celltrion
2.5.1 Celltrion Details
2.5.2 Celltrion Major Business
2.5.3 Celltrion Biosimilars & Follow-on-Biologics Product and Solutions
2.5.4 Celltrion Biosimilars & Follow-on-Biologics Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Celltrion Recent Developments and Future Plans
2.6 Biocon
2.6.1 Biocon Details
2.6.2 Biocon Major Business
2.6.3 Biocon Biosimilars & Follow-on-Biologics Product and Solutions
2.6.4 Biocon Biosimilars & Follow-on-Biologics Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Biocon Recent Developments and Future Plans
2.7 Hospira
2.7.1 Hospira Details
2.7.2 Hospira Major Business
2.7.3 Hospira Biosimilars & Follow-on-Biologics Product and Solutions
2.7.4 Hospira Biosimilars & Follow-on-Biologics Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Hospira Recent Developments and Future Plans
2.8 Merck Group
2.8.1 Merck Group Details
2.8.2 Merck Group Major Business
2.8.3 Merck Group Biosimilars & Follow-on-Biologics Product and Solutions
2.8.4 Merck Group Biosimilars & Follow-on-Biologics Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Merck Group Recent Developments and Future Plans
2.9 Biogen idec, Inc.
2.9.1 Biogen idec, Inc. Details
2.9.2 Biogen idec, Inc. Major Business
2.9.3 Biogen idec, Inc. Biosimilars & Follow-on-Biologics Product and Solutions
2.9.4 Biogen idec, Inc. Biosimilars & Follow-on-Biologics Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Biogen idec, Inc. Recent Developments and Future Plans
2.10 Genentech (Roche Group)
2.10.1 Genentech (Roche Group) Details
2.10.2 Genentech (Roche Group) Major Business
2.10.3 Genentech (Roche Group) Biosimilars & Follow-on-Biologics Product and Solutions
2.10.4 Genentech (Roche Group) Biosimilars & Follow-on-Biologics Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Genentech (Roche Group) Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Biosimilars & Follow-on-Biologics Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Biosimilars & Follow-on-Biologics by Company Revenue
3.2.2 Top 3 Biosimilars & Follow-on-Biologics Players Market Share in 2023
3.2.3 Top 6 Biosimilars & Follow-on-Biologics Players Market Share in 2023
3.3 Biosimilars & Follow-on-Biologics Market: Overall Company Footprint Analysis
3.3.1 Biosimilars & Follow-on-Biologics Market: Region Footprint
3.3.2 Biosimilars & Follow-on-Biologics Market: Company Product Type Footprint
3.3.3 Biosimilars & Follow-on-Biologics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Biosimilars & Follow-on-Biologics Consumption Value and Market Share by Type (2019-2024)
4.2 Global Biosimilars & Follow-on-Biologics Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Biosimilars & Follow-on-Biologics Consumption Value Market Share by Application (2019-2024)
5.2 Global Biosimilars & Follow-on-Biologics Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Biosimilars & Follow-on-Biologics Consumption Value by Type (2019-2030)
6.2 North America Biosimilars & Follow-on-Biologics Consumption Value by Application (2019-2030)
6.3 North America Biosimilars & Follow-on-Biologics Market Size by Country
6.3.1 North America Biosimilars & Follow-on-Biologics Consumption Value by Country (2019-2030)
6.3.2 United States Biosimilars & Follow-on-Biologics Market Size and Forecast (2019-2030)
6.3.3 Canada Biosimilars & Follow-on-Biologics Market Size and Forecast (2019-2030)
6.3.4 Mexico Biosimilars & Follow-on-Biologics Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Biosimilars & Follow-on-Biologics Consumption Value by Type (2019-2030)
7.2 Europe Biosimilars & Follow-on-Biologics Consumption Value by Application (2019-2030)
7.3 Europe Biosimilars & Follow-on-Biologics Market Size by Country
7.3.1 Europe Biosimilars & Follow-on-Biologics Consumption Value by Country (2019-2030)
7.3.2 Germany Biosimilars & Follow-on-Biologics Market Size and Forecast (2019-2030)
7.3.3 France Biosimilars & Follow-on-Biologics Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Biosimilars & Follow-on-Biologics Market Size and Forecast (2019-2030)
7.3.5 Russia Biosimilars & Follow-on-Biologics Market Size and Forecast (2019-2030)
7.3.6 Italy Biosimilars & Follow-on-Biologics Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Biosimilars & Follow-on-Biologics Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Biosimilars & Follow-on-Biologics Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Biosimilars & Follow-on-Biologics Market Size by Region
8.3.1 Asia-Pacific Biosimilars & Follow-on-Biologics Consumption Value by Region (2019-2030)
8.3.2 China Biosimilars & Follow-on-Biologics Market Size and Forecast (2019-2030)
8.3.3 Japan Biosimilars & Follow-on-Biologics Market Size and Forecast (2019-2030)
8.3.4 South Korea Biosimilars & Follow-on-Biologics Market Size and Forecast (2019-2030)
8.3.5 India Biosimilars & Follow-on-Biologics Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Biosimilars & Follow-on-Biologics Market Size and Forecast (2019-2030)
8.3.7 Australia Biosimilars & Follow-on-Biologics Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Biosimilars & Follow-on-Biologics Consumption Value by Type (2019-2030)
9.2 South America Biosimilars & Follow-on-Biologics Consumption Value by Application (2019-2030)
9.3 South America Biosimilars & Follow-on-Biologics Market Size by Country
9.3.1 South America Biosimilars & Follow-on-Biologics Consumption Value by Country (2019-2030)
9.3.2 Brazil Biosimilars & Follow-on-Biologics Market Size and Forecast (2019-2030)
9.3.3 Argentina Biosimilars & Follow-on-Biologics Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Biosimilars & Follow-on-Biologics Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Biosimilars & Follow-on-Biologics Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Biosimilars & Follow-on-Biologics Market Size by Country
10.3.1 Middle East & Africa Biosimilars & Follow-on-Biologics Consumption Value by Country (2019-2030)
10.3.2 Turkey Biosimilars & Follow-on-Biologics Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Biosimilars & Follow-on-Biologics Market Size and Forecast (2019-2030)
10.3.4 UAE Biosimilars & Follow-on-Biologics Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Biosimilars & Follow-on-Biologics Market Drivers
11.2 Biosimilars & Follow-on-Biologics Market Restraints
11.3 Biosimilars & Follow-on-Biologics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Biosimilars & Follow-on-Biologics Industry Chain
12.2 Biosimilars & Follow-on-Biologics Upstream Analysis
12.3 Biosimilars & Follow-on-Biologics Midstream Analysis
12.4 Biosimilars & Follow-on-Biologics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Biosimilars & Follow-on-Biologics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Biosimilars & Follow-on-Biologics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Biosimilars & Follow-on-Biologics Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Biosimilars & Follow-on-Biologics Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Novartis Company Information, Head Office, and Major Competitors
Table 6. Novartis Major Business
Table 7. Novartis Biosimilars & Follow-on-Biologics Product and Solutions
Table 8. Novartis Biosimilars & Follow-on-Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Novartis Recent Developments and Future Plans
Table 10. Synthon Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 11. Synthon Pharmaceuticals Major Business
Table 12. Synthon Pharmaceuticals Biosimilars & Follow-on-Biologics Product and Solutions
Table 13. Synthon Pharmaceuticals Biosimilars & Follow-on-Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Synthon Pharmaceuticals Recent Developments and Future Plans
Table 15. Teva Pharmaceutical Industries Company Information, Head Office, and Major Competitors
Table 16. Teva Pharmaceutical Industries Major Business
Table 17. Teva Pharmaceutical Industries Biosimilars & Follow-on-Biologics Product and Solutions
Table 18. Teva Pharmaceutical Industries Biosimilars & Follow-on-Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Teva Pharmaceutical Industries Recent Developments and Future Plans
Table 20. LG Life Sciences Company Information, Head Office, and Major Competitors
Table 21. LG Life Sciences Major Business
Table 22. LG Life Sciences Biosimilars & Follow-on-Biologics Product and Solutions
Table 23. LG Life Sciences Biosimilars & Follow-on-Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. LG Life Sciences Recent Developments and Future Plans
Table 25. Celltrion Company Information, Head Office, and Major Competitors
Table 26. Celltrion Major Business
Table 27. Celltrion Biosimilars & Follow-on-Biologics Product and Solutions
Table 28. Celltrion Biosimilars & Follow-on-Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Celltrion Recent Developments and Future Plans
Table 30. Biocon Company Information, Head Office, and Major Competitors
Table 31. Biocon Major Business
Table 32. Biocon Biosimilars & Follow-on-Biologics Product and Solutions
Table 33. Biocon Biosimilars & Follow-on-Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Biocon Recent Developments and Future Plans
Table 35. Hospira Company Information, Head Office, and Major Competitors
Table 36. Hospira Major Business
Table 37. Hospira Biosimilars & Follow-on-Biologics Product and Solutions
Table 38. Hospira Biosimilars & Follow-on-Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Hospira Recent Developments and Future Plans
Table 40. Merck Group Company Information, Head Office, and Major Competitors
Table 41. Merck Group Major Business
Table 42. Merck Group Biosimilars & Follow-on-Biologics Product and Solutions
Table 43. Merck Group Biosimilars & Follow-on-Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Merck Group Recent Developments and Future Plans
Table 45. Biogen idec, Inc. Company Information, Head Office, and Major Competitors
Table 46. Biogen idec, Inc. Major Business
Table 47. Biogen idec, Inc. Biosimilars & Follow-on-Biologics Product and Solutions
Table 48. Biogen idec, Inc. Biosimilars & Follow-on-Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Biogen idec, Inc. Recent Developments and Future Plans
Table 50. Genentech (Roche Group) Company Information, Head Office, and Major Competitors
Table 51. Genentech (Roche Group) Major Business
Table 52. Genentech (Roche Group) Biosimilars & Follow-on-Biologics Product and Solutions
Table 53. Genentech (Roche Group) Biosimilars & Follow-on-Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Genentech (Roche Group) Recent Developments and Future Plans
Table 55. Global Biosimilars & Follow-on-Biologics Revenue (USD Million) by Players (2019-2024)
Table 56. Global Biosimilars & Follow-on-Biologics Revenue Share by Players (2019-2024)
Table 57. Breakdown of Biosimilars & Follow-on-Biologics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Biosimilars & Follow-on-Biologics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 59. Head Office of Key Biosimilars & Follow-on-Biologics Players
Table 60. Biosimilars & Follow-on-Biologics Market: Company Product Type Footprint
Table 61. Biosimilars & Follow-on-Biologics Market: Company Product Application Footprint
Table 62. Biosimilars & Follow-on-Biologics New Market Entrants and Barriers to Market Entry
Table 63. Biosimilars & Follow-on-Biologics Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Biosimilars & Follow-on-Biologics Consumption Value (USD Million) by Type (2019-2024)
Table 65. Global Biosimilars & Follow-on-Biologics Consumption Value Share by Type (2019-2024)
Table 66. Global Biosimilars & Follow-on-Biologics Consumption Value Forecast by Type (2025-2030)
Table 67. Global Biosimilars & Follow-on-Biologics Consumption Value by Application (2019-2024)
Table 68. Global Biosimilars & Follow-on-Biologics Consumption Value Forecast by Application (2025-2030)
Table 69. North America Biosimilars & Follow-on-Biologics Consumption Value by Type (2019-2024) & (USD Million)
Table 70. North America Biosimilars & Follow-on-Biologics Consumption Value by Type (2025-2030) & (USD Million)
Table 71. North America Biosimilars & Follow-on-Biologics Consumption Value by Application (2019-2024) & (USD Million)
Table 72. North America Biosimilars & Follow-on-Biologics Consumption Value by Application (2025-2030) & (USD Million)
Table 73. North America Biosimilars & Follow-on-Biologics Consumption Value by Country (2019-2024) & (USD Million)
Table 74. North America Biosimilars & Follow-on-Biologics Consumption Value by Country (2025-2030) & (USD Million)
Table 75. Europe Biosimilars & Follow-on-Biologics Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Europe Biosimilars & Follow-on-Biologics Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Europe Biosimilars & Follow-on-Biologics Consumption Value by Application (2019-2024) & (USD Million)
Table 78. Europe Biosimilars & Follow-on-Biologics Consumption Value by Application (2025-2030) & (USD Million)
Table 79. Europe Biosimilars & Follow-on-Biologics Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe Biosimilars & Follow-on-Biologics Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific Biosimilars & Follow-on-Biologics Consumption Value by Type (2019-2024) & (USD Million)
Table 82. Asia-Pacific Biosimilars & Follow-on-Biologics Consumption Value by Type (2025-2030) & (USD Million)
Table 83. Asia-Pacific Biosimilars & Follow-on-Biologics Consumption Value by Application (2019-2024) & (USD Million)
Table 84. Asia-Pacific Biosimilars & Follow-on-Biologics Consumption Value by Application (2025-2030) & (USD Million)
Table 85. Asia-Pacific Biosimilars & Follow-on-Biologics Consumption Value by Region (2019-2024) & (USD Million)
Table 86. Asia-Pacific Biosimilars & Follow-on-Biologics Consumption Value by Region (2025-2030) & (USD Million)
Table 87. South America Biosimilars & Follow-on-Biologics Consumption Value by Type (2019-2024) & (USD Million)
Table 88. South America Biosimilars & Follow-on-Biologics Consumption Value by Type (2025-2030) & (USD Million)
Table 89. South America Biosimilars & Follow-on-Biologics Consumption Value by Application (2019-2024) & (USD Million)
Table 90. South America Biosimilars & Follow-on-Biologics Consumption Value by Application (2025-2030) & (USD Million)
Table 91. South America Biosimilars & Follow-on-Biologics Consumption Value by Country (2019-2024) & (USD Million)
Table 92. South America Biosimilars & Follow-on-Biologics Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Middle East & Africa Biosimilars & Follow-on-Biologics Consumption Value by Type (2019-2024) & (USD Million)
Table 94. Middle East & Africa Biosimilars & Follow-on-Biologics Consumption Value by Type (2025-2030) & (USD Million)
Table 95. Middle East & Africa Biosimilars & Follow-on-Biologics Consumption Value by Application (2019-2024) & (USD Million)
Table 96. Middle East & Africa Biosimilars & Follow-on-Biologics Consumption Value by Application (2025-2030) & (USD Million)
Table 97. Middle East & Africa Biosimilars & Follow-on-Biologics Consumption Value by Country (2019-2024) & (USD Million)
Table 98. Middle East & Africa Biosimilars & Follow-on-Biologics Consumption Value by Country (2025-2030) & (USD Million)
Table 99. Biosimilars & Follow-on-Biologics Raw Material
Table 100. Key Suppliers of Biosimilars & Follow-on-Biologics Raw Materials
Table 1. Global Biosimilars & Follow-on-Biologics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Biosimilars & Follow-on-Biologics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Biosimilars & Follow-on-Biologics Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Biosimilars & Follow-on-Biologics Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Novartis Company Information, Head Office, and Major Competitors
Table 6. Novartis Major Business
Table 7. Novartis Biosimilars & Follow-on-Biologics Product and Solutions
Table 8. Novartis Biosimilars & Follow-on-Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Novartis Recent Developments and Future Plans
Table 10. Synthon Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 11. Synthon Pharmaceuticals Major Business
Table 12. Synthon Pharmaceuticals Biosimilars & Follow-on-Biologics Product and Solutions
Table 13. Synthon Pharmaceuticals Biosimilars & Follow-on-Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Synthon Pharmaceuticals Recent Developments and Future Plans
Table 15. Teva Pharmaceutical Industries Company Information, Head Office, and Major Competitors
Table 16. Teva Pharmaceutical Industries Major Business
Table 17. Teva Pharmaceutical Industries Biosimilars & Follow-on-Biologics Product and Solutions
Table 18. Teva Pharmaceutical Industries Biosimilars & Follow-on-Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Teva Pharmaceutical Industries Recent Developments and Future Plans
Table 20. LG Life Sciences Company Information, Head Office, and Major Competitors
Table 21. LG Life Sciences Major Business
Table 22. LG Life Sciences Biosimilars & Follow-on-Biologics Product and Solutions
Table 23. LG Life Sciences Biosimilars & Follow-on-Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. LG Life Sciences Recent Developments and Future Plans
Table 25. Celltrion Company Information, Head Office, and Major Competitors
Table 26. Celltrion Major Business
Table 27. Celltrion Biosimilars & Follow-on-Biologics Product and Solutions
Table 28. Celltrion Biosimilars & Follow-on-Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Celltrion Recent Developments and Future Plans
Table 30. Biocon Company Information, Head Office, and Major Competitors
Table 31. Biocon Major Business
Table 32. Biocon Biosimilars & Follow-on-Biologics Product and Solutions
Table 33. Biocon Biosimilars & Follow-on-Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Biocon Recent Developments and Future Plans
Table 35. Hospira Company Information, Head Office, and Major Competitors
Table 36. Hospira Major Business
Table 37. Hospira Biosimilars & Follow-on-Biologics Product and Solutions
Table 38. Hospira Biosimilars & Follow-on-Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Hospira Recent Developments and Future Plans
Table 40. Merck Group Company Information, Head Office, and Major Competitors
Table 41. Merck Group Major Business
Table 42. Merck Group Biosimilars & Follow-on-Biologics Product and Solutions
Table 43. Merck Group Biosimilars & Follow-on-Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Merck Group Recent Developments and Future Plans
Table 45. Biogen idec, Inc. Company Information, Head Office, and Major Competitors
Table 46. Biogen idec, Inc. Major Business
Table 47. Biogen idec, Inc. Biosimilars & Follow-on-Biologics Product and Solutions
Table 48. Biogen idec, Inc. Biosimilars & Follow-on-Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Biogen idec, Inc. Recent Developments and Future Plans
Table 50. Genentech (Roche Group) Company Information, Head Office, and Major Competitors
Table 51. Genentech (Roche Group) Major Business
Table 52. Genentech (Roche Group) Biosimilars & Follow-on-Biologics Product and Solutions
Table 53. Genentech (Roche Group) Biosimilars & Follow-on-Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Genentech (Roche Group) Recent Developments and Future Plans
Table 55. Global Biosimilars & Follow-on-Biologics Revenue (USD Million) by Players (2019-2024)
Table 56. Global Biosimilars & Follow-on-Biologics Revenue Share by Players (2019-2024)
Table 57. Breakdown of Biosimilars & Follow-on-Biologics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Biosimilars & Follow-on-Biologics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 59. Head Office of Key Biosimilars & Follow-on-Biologics Players
Table 60. Biosimilars & Follow-on-Biologics Market: Company Product Type Footprint
Table 61. Biosimilars & Follow-on-Biologics Market: Company Product Application Footprint
Table 62. Biosimilars & Follow-on-Biologics New Market Entrants and Barriers to Market Entry
Table 63. Biosimilars & Follow-on-Biologics Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Biosimilars & Follow-on-Biologics Consumption Value (USD Million) by Type (2019-2024)
Table 65. Global Biosimilars & Follow-on-Biologics Consumption Value Share by Type (2019-2024)
Table 66. Global Biosimilars & Follow-on-Biologics Consumption Value Forecast by Type (2025-2030)
Table 67. Global Biosimilars & Follow-on-Biologics Consumption Value by Application (2019-2024)
Table 68. Global Biosimilars & Follow-on-Biologics Consumption Value Forecast by Application (2025-2030)
Table 69. North America Biosimilars & Follow-on-Biologics Consumption Value by Type (2019-2024) & (USD Million)
Table 70. North America Biosimilars & Follow-on-Biologics Consumption Value by Type (2025-2030) & (USD Million)
Table 71. North America Biosimilars & Follow-on-Biologics Consumption Value by Application (2019-2024) & (USD Million)
Table 72. North America Biosimilars & Follow-on-Biologics Consumption Value by Application (2025-2030) & (USD Million)
Table 73. North America Biosimilars & Follow-on-Biologics Consumption Value by Country (2019-2024) & (USD Million)
Table 74. North America Biosimilars & Follow-on-Biologics Consumption Value by Country (2025-2030) & (USD Million)
Table 75. Europe Biosimilars & Follow-on-Biologics Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Europe Biosimilars & Follow-on-Biologics Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Europe Biosimilars & Follow-on-Biologics Consumption Value by Application (2019-2024) & (USD Million)
Table 78. Europe Biosimilars & Follow-on-Biologics Consumption Value by Application (2025-2030) & (USD Million)
Table 79. Europe Biosimilars & Follow-on-Biologics Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe Biosimilars & Follow-on-Biologics Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific Biosimilars & Follow-on-Biologics Consumption Value by Type (2019-2024) & (USD Million)
Table 82. Asia-Pacific Biosimilars & Follow-on-Biologics Consumption Value by Type (2025-2030) & (USD Million)
Table 83. Asia-Pacific Biosimilars & Follow-on-Biologics Consumption Value by Application (2019-2024) & (USD Million)
Table 84. Asia-Pacific Biosimilars & Follow-on-Biologics Consumption Value by Application (2025-2030) & (USD Million)
Table 85. Asia-Pacific Biosimilars & Follow-on-Biologics Consumption Value by Region (2019-2024) & (USD Million)
Table 86. Asia-Pacific Biosimilars & Follow-on-Biologics Consumption Value by Region (2025-2030) & (USD Million)
Table 87. South America Biosimilars & Follow-on-Biologics Consumption Value by Type (2019-2024) & (USD Million)
Table 88. South America Biosimilars & Follow-on-Biologics Consumption Value by Type (2025-2030) & (USD Million)
Table 89. South America Biosimilars & Follow-on-Biologics Consumption Value by Application (2019-2024) & (USD Million)
Table 90. South America Biosimilars & Follow-on-Biologics Consumption Value by Application (2025-2030) & (USD Million)
Table 91. South America Biosimilars & Follow-on-Biologics Consumption Value by Country (2019-2024) & (USD Million)
Table 92. South America Biosimilars & Follow-on-Biologics Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Middle East & Africa Biosimilars & Follow-on-Biologics Consumption Value by Type (2019-2024) & (USD Million)
Table 94. Middle East & Africa Biosimilars & Follow-on-Biologics Consumption Value by Type (2025-2030) & (USD Million)
Table 95. Middle East & Africa Biosimilars & Follow-on-Biologics Consumption Value by Application (2019-2024) & (USD Million)
Table 96. Middle East & Africa Biosimilars & Follow-on-Biologics Consumption Value by Application (2025-2030) & (USD Million)
Table 97. Middle East & Africa Biosimilars & Follow-on-Biologics Consumption Value by Country (2019-2024) & (USD Million)
Table 98. Middle East & Africa Biosimilars & Follow-on-Biologics Consumption Value by Country (2025-2030) & (USD Million)
Table 99. Biosimilars & Follow-on-Biologics Raw Material
Table 100. Key Suppliers of Biosimilars & Follow-on-Biologics Raw Materials
LIST OF FIGURES
Figure 1. Biosimilars & Follow-on-Biologics Picture
Figure 2. Global Biosimilars & Follow-on-Biologics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Biosimilars & Follow-on-Biologics Consumption Value Market Share by Type in 2023
Figure 4. Human Growth Hormone
Figure 5. Erythropoietin
Figure 6. Monoclonal Antibodies
Figure 7. Insulin
Figure 8. Interferon
Figure 9. Granulocyte-Colony Stimulating Factor
Figure 10. Peptide
Figure 11. Others
Figure 12. Global Biosimilars & Follow-on-Biologics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 13. Biosimilars & Follow-on-Biologics Consumption Value Market Share by Application in 2023
Figure 14. Blood Disorders Picture
Figure 15. Oncology Diseases Picture
Figure 16. Chronic and Autoimmune Diseases Picture
Figure 17. Growth Hormone Deficiencies Picture
Figure 18. Others Picture
Figure 19. Global Biosimilars & Follow-on-Biologics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 20. Global Biosimilars & Follow-on-Biologics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 21. Global Market Biosimilars & Follow-on-Biologics Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 22. Global Biosimilars & Follow-on-Biologics Consumption Value Market Share by Region (2019-2030)
Figure 23. Global Biosimilars & Follow-on-Biologics Consumption Value Market Share by Region in 2023
Figure 24. North America Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 25. Europe Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 26. Asia-Pacific Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 27. South America Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 28. Middle East and Africa Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 29. Global Biosimilars & Follow-on-Biologics Revenue Share by Players in 2023
Figure 30. Biosimilars & Follow-on-Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 31. Global Top 3 Players Biosimilars & Follow-on-Biologics Market Share in 2023
Figure 32. Global Top 6 Players Biosimilars & Follow-on-Biologics Market Share in 2023
Figure 33. Global Biosimilars & Follow-on-Biologics Consumption Value Share by Type (2019-2024)
Figure 34. Global Biosimilars & Follow-on-Biologics Market Share Forecast by Type (2025-2030)
Figure 35. Global Biosimilars & Follow-on-Biologics Consumption Value Share by Application (2019-2024)
Figure 36. Global Biosimilars & Follow-on-Biologics Market Share Forecast by Application (2025-2030)
Figure 37. North America Biosimilars & Follow-on-Biologics Consumption Value Market Share by Type (2019-2030)
Figure 38. North America Biosimilars & Follow-on-Biologics Consumption Value Market Share by Application (2019-2030)
Figure 39. North America Biosimilars & Follow-on-Biologics Consumption Value Market Share by Country (2019-2030)
Figure 40. United States Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 41. Canada Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 42. Mexico Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 43. Europe Biosimilars & Follow-on-Biologics Consumption Value Market Share by Type (2019-2030)
Figure 44. Europe Biosimilars & Follow-on-Biologics Consumption Value Market Share by Application (2019-2030)
Figure 45. Europe Biosimilars & Follow-on-Biologics Consumption Value Market Share by Country (2019-2030)
Figure 46. Germany Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 47. France Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 48. United Kingdom Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 49. Russia Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 50. Italy Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 51. Asia-Pacific Biosimilars & Follow-on-Biologics Consumption Value Market Share by Type (2019-2030)
Figure 52. Asia-Pacific Biosimilars & Follow-on-Biologics Consumption Value Market Share by Application (2019-2030)
Figure 53. Asia-Pacific Biosimilars & Follow-on-Biologics Consumption Value Market Share by Region (2019-2030)
Figure 54. China Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 55. Japan Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 56. South Korea Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 57. India Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 58. Southeast Asia Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 59. Australia Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 60. South America Biosimilars & Follow-on-Biologics Consumption Value Market Share by Type (2019-2030)
Figure 61. South America Biosimilars & Follow-on-Biologics Consumption Value Market Share by Application (2019-2030)
Figure 62. South America Biosimilars & Follow-on-Biologics Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 64. Argentina Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 65. Middle East and Africa Biosimilars & Follow-on-Biologics Consumption Value Market Share by Type (2019-2030)
Figure 66. Middle East and Africa Biosimilars & Follow-on-Biologics Consumption Value Market Share by Application (2019-2030)
Figure 67. Middle East and Africa Biosimilars & Follow-on-Biologics Consumption Value Market Share by Country (2019-2030)
Figure 68. Turkey Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 69. Saudi Arabia Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 70. UAE Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 71. Biosimilars & Follow-on-Biologics Market Drivers
Figure 72. Biosimilars & Follow-on-Biologics Market Restraints
Figure 73. Biosimilars & Follow-on-Biologics Market Trends
Figure 74. Porters Five Forces Analysis
Figure 75. Manufacturing Cost Structure Analysis of Biosimilars & Follow-on-Biologics in 2023
Figure 76. Manufacturing Process Analysis of Biosimilars & Follow-on-Biologics
Figure 77. Biosimilars & Follow-on-Biologics Industrial Chain
Figure 78. Methodology
Figure 79. Research Process and Data Source
Figure 1. Biosimilars & Follow-on-Biologics Picture
Figure 2. Global Biosimilars & Follow-on-Biologics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Biosimilars & Follow-on-Biologics Consumption Value Market Share by Type in 2023
Figure 4. Human Growth Hormone
Figure 5. Erythropoietin
Figure 6. Monoclonal Antibodies
Figure 7. Insulin
Figure 8. Interferon
Figure 9. Granulocyte-Colony Stimulating Factor
Figure 10. Peptide
Figure 11. Others
Figure 12. Global Biosimilars & Follow-on-Biologics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 13. Biosimilars & Follow-on-Biologics Consumption Value Market Share by Application in 2023
Figure 14. Blood Disorders Picture
Figure 15. Oncology Diseases Picture
Figure 16. Chronic and Autoimmune Diseases Picture
Figure 17. Growth Hormone Deficiencies Picture
Figure 18. Others Picture
Figure 19. Global Biosimilars & Follow-on-Biologics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 20. Global Biosimilars & Follow-on-Biologics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 21. Global Market Biosimilars & Follow-on-Biologics Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 22. Global Biosimilars & Follow-on-Biologics Consumption Value Market Share by Region (2019-2030)
Figure 23. Global Biosimilars & Follow-on-Biologics Consumption Value Market Share by Region in 2023
Figure 24. North America Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 25. Europe Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 26. Asia-Pacific Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 27. South America Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 28. Middle East and Africa Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 29. Global Biosimilars & Follow-on-Biologics Revenue Share by Players in 2023
Figure 30. Biosimilars & Follow-on-Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 31. Global Top 3 Players Biosimilars & Follow-on-Biologics Market Share in 2023
Figure 32. Global Top 6 Players Biosimilars & Follow-on-Biologics Market Share in 2023
Figure 33. Global Biosimilars & Follow-on-Biologics Consumption Value Share by Type (2019-2024)
Figure 34. Global Biosimilars & Follow-on-Biologics Market Share Forecast by Type (2025-2030)
Figure 35. Global Biosimilars & Follow-on-Biologics Consumption Value Share by Application (2019-2024)
Figure 36. Global Biosimilars & Follow-on-Biologics Market Share Forecast by Application (2025-2030)
Figure 37. North America Biosimilars & Follow-on-Biologics Consumption Value Market Share by Type (2019-2030)
Figure 38. North America Biosimilars & Follow-on-Biologics Consumption Value Market Share by Application (2019-2030)
Figure 39. North America Biosimilars & Follow-on-Biologics Consumption Value Market Share by Country (2019-2030)
Figure 40. United States Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 41. Canada Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 42. Mexico Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 43. Europe Biosimilars & Follow-on-Biologics Consumption Value Market Share by Type (2019-2030)
Figure 44. Europe Biosimilars & Follow-on-Biologics Consumption Value Market Share by Application (2019-2030)
Figure 45. Europe Biosimilars & Follow-on-Biologics Consumption Value Market Share by Country (2019-2030)
Figure 46. Germany Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 47. France Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 48. United Kingdom Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 49. Russia Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 50. Italy Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 51. Asia-Pacific Biosimilars & Follow-on-Biologics Consumption Value Market Share by Type (2019-2030)
Figure 52. Asia-Pacific Biosimilars & Follow-on-Biologics Consumption Value Market Share by Application (2019-2030)
Figure 53. Asia-Pacific Biosimilars & Follow-on-Biologics Consumption Value Market Share by Region (2019-2030)
Figure 54. China Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 55. Japan Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 56. South Korea Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 57. India Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 58. Southeast Asia Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 59. Australia Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 60. South America Biosimilars & Follow-on-Biologics Consumption Value Market Share by Type (2019-2030)
Figure 61. South America Biosimilars & Follow-on-Biologics Consumption Value Market Share by Application (2019-2030)
Figure 62. South America Biosimilars & Follow-on-Biologics Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 64. Argentina Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 65. Middle East and Africa Biosimilars & Follow-on-Biologics Consumption Value Market Share by Type (2019-2030)
Figure 66. Middle East and Africa Biosimilars & Follow-on-Biologics Consumption Value Market Share by Application (2019-2030)
Figure 67. Middle East and Africa Biosimilars & Follow-on-Biologics Consumption Value Market Share by Country (2019-2030)
Figure 68. Turkey Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 69. Saudi Arabia Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 70. UAE Biosimilars & Follow-on-Biologics Consumption Value (2019-2030) & (USD Million)
Figure 71. Biosimilars & Follow-on-Biologics Market Drivers
Figure 72. Biosimilars & Follow-on-Biologics Market Restraints
Figure 73. Biosimilars & Follow-on-Biologics Market Trends
Figure 74. Porters Five Forces Analysis
Figure 75. Manufacturing Cost Structure Analysis of Biosimilars & Follow-on-Biologics in 2023
Figure 76. Manufacturing Process Analysis of Biosimilars & Follow-on-Biologics
Figure 77. Biosimilars & Follow-on-Biologics Industrial Chain
Figure 78. Methodology
Figure 79. Research Process and Data Source
